Heartseed Inc. announced that it has received $37 million (¥4 billion) in Series C round of funding on June 11, 2021. The transaction included participation from new investor UTokyo Innovation Platform Co., Ltd., Medical Incubator Japan K.K., Keio Innovation Initiative Inc., Sumitomo Mitsui Trust Investment Co., Ltd., existing investors SBI Investment Co., Ltd., Nissay Capital Co., Ltd., SMBC Venture Capital Co., Ltd., MediPal Holdings Corporation (TSE:7459), ITOCHU CHEMICAL FRONTIER Corporation. The company has raised $75 million (¥8.2 billion) in funding till date.